Sectoral Asset Management’s Integra LifeSciences IART Stock Holding History

Sectoral Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,000	Closed	-$517K	–	131
2020 Q2	$517K	Buy	+11,000	New	+$541K	0.05%	139
2018 Q2	–	Sell	-123,198	Closed	-$6.82M	–	71
2018 Q1	$6.82M	Hold	123,198	–	–	0.75%	48
2017 Q4	$5.9M	Sell	123,198 -17,580	-12%	-$860K	0.74%	43
2017 Q3	$7.11M	Sell	140,778 -103,220	-42%	-$5.3M	0.92%	37
2017 Q2	$13.3M	Buy	243,998 +41,499	+20%	+$1.98M	1.45%	28
2017 Q1	$8.53M	Buy	202,499 +64,099	+46%	+$2.74M	1%	30
2016 Q4	$5.94M	Hold	138,400	–	–	0.66%	36
2016 Q3	$5.71M	Buy	138,400 +17,280	+14%	+$724K	0.56%	41
2016 Q2	$4.83M	Hold	121,120	–	–	0.5%	41
2016 Q1	$4.08M	Buy	+121,120	New	+$3.77M	0.2%	62
2015 Q3	–	Sell	-232	Closed	-$6K	–	85
2015 Q2	$6K	Buy	+232	New	+$6.18K	﹤0.01%	90

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Sectoral Asset Management's IART Position: Q3 2020 in Review

Sectoral Asset Management sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 11,000 shares — an estimated $517K sold.

Sectoral Asset Management first reported a position in IART in Q2 2015 and held it in 11 quarters. The position peaked at $13.3M in Q2 2017. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Sectoral Asset Management reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
Sectoral Asset Management sold 11,000 Integra LifeSciences shares in Q3 2020, an estimated $517K.
Sectoral Asset Management first reported a position in Integra LifeSciences in Q2 2015 and held it in 11 quarters.
Sectoral Asset Management's Integra LifeSciences position peaked at $13.3M in Q2 2017.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.